I The rate of acid secretion and mucosal cyclic adenosine 3',5'-monophosphate (cyclic AMP) content 3 Each of the three drugs caused an increase in both the mucosal cyclic AMP content and the rate of acid secretion. These increases were linearly related to the logarithm of drug concentration for each drug. 4 There were no statistically significant differences between the three regression coefficients obtained for acid on drug and for cyclic AMP on drug. 5 There was a significant correlation between the rate of acid secretion and mucosal cyclic AMP content in stimulated preparations (P < 0.001) and also in control preparations which received no drug (P< 0.05).
Introduction
Cyclic adenosine 3',5'-monophosphate (cyclic AMP) has been implicated as the intracellular mediator of a diverse range of physiological responses. Its possible role as a mediator of acid secretion in the mammalian stomach has been recently reviewed (Amer, 1972;  Kimberg, 1974) . Amer concluded that increased cyclic AMP in the stomach was associated with a decrease in acid secretion. He explained the stimulatory effects of phosphodiesterase inhibitors in terms of changes in the microcirculation to the mucosa and alterations in the calcium ion permeability of the cells. However, Kimberg concluded that, in some mammalian species at least, acid secretion was associated with an increase in cyclic AMP. More recent publications (Ruoff & Sewing, 1974; Katsumata & Glick, 1975) have added further support to the hypothesis that increased acid secretion is associated with increased cyclic AMP in the rat stomach. If acid secretion is regulated by the cyclic AMP content of the mucosa one would expect there to be a quantitative relationship between mucosal cyclic AMP and the rate of acid secretion. This paper describes experiments in which the rate of acid secretion and the mucosal cyclic AMP content have been measured on the same guinea-pig isolated stomach preparation. The use of an in vitro preparation has the advantage that the results are not complicated by changes in either mucosal blood flow or circulating hormone levels which might occur in an intact animal. Some preliminary results have been communicated to the Physiological Society (Canfield, Curwain & Spencer, 1976 ).
Methods
The preparation and general procedures are those described previously by Holton & Spencer (1976 Amersham, 1975) . Tritium was counted on a Hewlett-Packard Tricarb liquid scintillation counter using a methanol/toluene scintillator.
Drugs and chemicals
The following were used as stimulants; theophylline hydrate (BDH), 2 amino-6-methyl-5-oxo-4-n-propyl-4,5-didhydro-s-triazolo (1,5-a) pyrimidine (ICI 63197) , histamine acid phosphate (1 mg/ml; Macarthys) and dibutyryl cyclic AMP (Sigma). These were always added to the serosal bathing fluid.
Experimental design
The tissue bath accomodated 6 half-stomach preparations from 3 animals. Two were used as controls (0), two for one drug dose (A) and two for another (B). This provided three 'dose pairs'; (OA), (OB) and (AB) which were randomly allocated to the 3 animals. The allocation of the dose pair within the half-stomach pair was also randomized.
This design was adopted to facilitate a comparison between the two half-stomachs from the same animal. However, examination of the results indicated that the within animal variance was not any smaller than that between animals. Consequently, each half-stomach has been treated as an individual observation for the purposes of statistical analysis.
In a few experiments, accurate estimates of the acid secretory rate were not obtained. This was due to leakage of bicarbonate from the serosal bathing fluid resulting from physical damage to the preparation by the tube used to remove the mucosal bathing fluid. There are more values for cyclic AMP than acid because accurate estimates of acid secretion were not obtained from some tissues for reasons described in the Methods section. The inclusion of those 'extra' points for cyclic AMP is justified when one is estimating the effects of drug concentrations on a single parameter. Both the rate of acid secretion and cyclic AMP content were linearly related to the logarithm of the drug concentration over the range used for both drugs (P <0.05 in all four cases). The values of the regression coefficients of acid on drug concentration were not significantly different for the two drugs, nor were those for cyclic AMP on drug concentration. However, ICI 63197 is more potent than theophylline on a molar basis.
Reversal ofthe effect oftheophylline
The effect of theophylline on the rate of acid secretion is readily reversible (Holton & Spencer, 1976 Figure 2 shows the relation between the rate of acid production and the logarithm of histamine concentra-tion and cyclic AMP content and the logarithm of histamine concentration. Both parameters were linearly related to the logarithm of drug concentration and the regression coefficients for acid on histamine and cyclic AMP on histamine were not significantly different from those obtained with the phosphodiesterase inhibitors. This is summarized in Table 2 .
Dibutyryl cyclic AMP
The rate of acid secretion of 5 preparations was increased by an average of 25% following application of 1 mM dibutyryl cyclic AMP. This increase was not statistically significant. Addition of 1 mM dibutyryl cyclic AMP during a plateau response to 1 mM theophylline caused a further 50% increase in the rate of acid secretion above the theophylline plateau. This increase was significant (P < 0.01).
Relationship between mucosal cyclic AMP and rate of acid secretion The linear regression coefficient of the rate of acid secretion on the cyclic AMP content of the mucosa obtained from the covariance analysis of the control data did not differ significantly from that obtained from the analysis of the stimulated tissues.
Discussion
Interpretation of these results is complicated by the fact that the gastric mucosa is a heterogeneous tissue. The extraction technique used in this work does not selectively measure the cyclic AMP content of the parietal cells which are responsible for acid secretion. Katsumata & Glick (1975) have shown that histamine causes an increase in the cyclic AMP content only in the parietal-mucus neck cell layer of the rat gastric mucosa whilst theophylline has a similar effect and also causes a smaller increase in the cyclic AMP content of the chief cell layer. As there are no statistically significant differences between our results for histamine and theophylline we feel it is reasonable to assume that most of the changes in cyclic AMP we have observed have taken place in the parietal-mucus neck cell layer but must bear in mind possible species differences between rat and guinea-pig. The action of theophylline and histamine on acid secretion confirm earlier findings (Holton & Spencer, 1976) Domschke, Domschke, Classen & Demling (1973) obtained from the intact rat. The phosphodiesterase inhibitors might be stimulating acid secretion via a mechanism involving calcium as suggested by Amer (1972) with a concentration-dependent increase in cyclic AMP as a side effect. However, there is no evidence that histamine changes calcium permeability but it has been reported to stimulate adenyl cyclase activity in the gastric mucosa of rat and rabbit. (Bersimbaev, Argutinskaya & Salganik, 1971; Sung, Jenkins, Bums, Hackney, Spenney, Sachs & Wiebelhaus, 1973) . Thus, an increase in the mucosal cyclic AMP content brought about by two different means, phosphodiesterase inhibition and adenyl cyclase activation, is associated with an increase in the rate of acid secretion in our experiments. Both the rate of acid secretion and the mucosal cyclic AMP content increased linearly with the logarithm of the drug concentration for all three drugs and the respective linear regression coefficients were not significantly different between the drugs (see Table 2 ). This does not mean that all three drugs are acting on a common mechanism nor does it prove a causal relationship between cyclic AMP content and the rate of acid secretion. However, it does suggest that there is no reason to treat the results from the three drugs seaparately and they were pooled for the purpose of the analysis of covariance. Again a significant correlation is not proof of a causal relationship between the parameters. We cannot, for example, completely exclude the possibility that the cyclic AMP content of the mucosa is affected by the concentration of acid in the mucosal bathing fluid which is a function of the drug concentration.
The non-significant increase in acid secretion in response to exogenous dibutyryl cyclic AMP in this preparation contrasts with findings on the rat (Brennan, Arbakov, Stefankiewicz & Groves, 1975) and rabbit (Fromm, Schwartz & Quijano, 1975) stomachs, but this may be due to a species difference in the metabolism of cyclic nucleotides. The potentiating effect of theophylline suggests that the rate of entry of dibutryryl cyclic AMP in this preparation may be so low that it is largely destroyed by the phosphodiesterase and a significant increase in acid secretion is only obtained when there is partial inhibition of this enzyme. However, Main & Whittle (1974) have shown that the stimulatory effect of dibutyryl cyclic AMP in the rat is potentiated by a threshold dose of histamine. We have not tested this with the guinea-pig preparation but it is of interest that both theophylline and histamine stimulation are associated with an increase in mucosal cyclic AMP content. It may be that the action of exogenous dibutyryl cyclic AMP is potentiated in some way by a simultaneous increase in endogenous cyclic AMP.
Our results indicate that acid secretion in control preparations is related to the mucosal cyclic AMP content. The stimulatory action of histamine and phosphodiesterase inhibitors may be due to their action in increasing the cyclic AMP content. This provides further evidence to support the hypothesis that cyclic AMP could be one of the factors in the regulation of acid secretion.
